Welcome to the
EVER Pharma Webinar
Platform.
We are happy to have you here!
On Demand
Neurorecovery in post-stroke complications – from emerging clinical evidence to patient centered benefits
ON DEMAND
Published on April 21, 2026
#stroke
New Hope for Stroke Patients - Results from a High-Quality Comparative Effectiveness Study
ON DEMAND
Published on December 4, 2025
#stroke
Is there sufficient evidence to include Cerebrolysin into treatment algorithms in AIS?
ON DEMAND
Published on March 18, 2025
#stroke
Opening the vessel is not enough – Is Cerebrolysin the answer to improved longterm outcome after recanalization therapy?
ON DEMAND
Published on November 19, 2024
#tbi
Cerebrolysin’s evidence from TBI research – Treat early, reduce acute and post-acute complications
ON DEMAND
Published on April 17, 2024
#tbi
Multidisciplinary Neurotrauma treatment - Panel Discussion about clinical reality and implementation strategies
ON DEMAND
Published on November 14, 2023
#stroke
Treatment strategies for motor impaired stroke patients
ON DEMAND
Published on June 14, 2023
#stroke
Cerebroprotective strategies in acute ischemic stroke - fiction or reality?
ON DEMAND
Published on March 16, 2023
#stroke
The future of chronic stroke patient treatment - Interactive case discussions
ON DEMAND
Published on December 1, 2022
#tbi
Neurorecovery - When evidence from the bench meets results at the bedside
ON DEMAND
Published on October 18, 2022
#neurocognitive disorders
Treating cognitive decline after critical illnesses - A call to action
ON DEMAND
Published on September 13, 2022
#stroke
New horizons improving gold standard therapy in acute stroke - Case discussions
ON DEMAND
Published on June 22, 2022